Amplification of epidermal growth factor receptor gene in gliomas: Histopathology and prognosis

Journal of Neuropathology and Experimental Neurology

Volumn 51, Issue 1, 1992, Pages 84-90

  Hurtt, Mark R ^a   Moossy, John ^a   Donovan Peluso, Maryann ^a   Locker, Joseph ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Aneuploidy; Chromosome 7; Gene amplification; Gliomas; Met; Polysomy; Prognosis

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR;

ADOLESCENT; ADULT; AGED; ANEUPLOIDY; ASTROCYTOMA; CHILD; CHROMOSOME 7; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DOT HYBRIDIZATION; FEMALE; GENE AMPLIFICATION; GENE DOSAGE; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; ONCOGENE C MYB; ONCOGENE C MYC; PRIORITY JOURNAL; PROGNOSIS;

ADULT; ANEUPLOIDY; ASTROCYTES; AUTORADIOGRAPHY; CHROMOSOME MAPPING; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; GLIOBLASTOMA; GLIOMA; HUMAN; MALE; MIDDLE AGE; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SUPPORT, NON-U.S. GOV'T;

EID: 0026570136     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/00005072-199201000-00010     Document Type: Article

References (27)

1. Stark GR, Giulotto E. Recent progress in understanding mechanisms of mammalian DNA amplification. Cell 1989;57:901–8
2. Bigner SH, Burger PC, Wong AJ, et al. Gene amplification in malignant human gliomas: Clinical and histopathologic aspects. J Neuropathol Exp Neurol 1988;47:191–205
3. Merkel DE, McGuire WL. Oncogenes and cancer prognosis. In: Devita VT, Heilman S, Rosenberg SA, eds. Important advances in oncology. Philadelphia: Lippincott, 1988:103–17
4. Bigner SH, Mark J, Mahaley MS, Bigner DD. Patterns of the early, gross chromosomal changes in malignant human gliomas. Hereditas 1984;101:103–13
5. Bigner SH, Mark J, Bullard DE, Mahaley MS Jr, Bigner DD. Chromosomal evolution in malignant human gliomas starts with specific and usually numerical deviations. Cancer Genet Cytogenet 1986; 22:121–35
6. Bigner SH, Wong AJ, Mark J, et al. Relationship between gene amplification and chromosomal deviations in malignant human gliomas. Cancer Genet Cytogenet 1987;29:165–70
7. Bigner SH, Mark J, Burger PC, et al. Specific chromosomal abnormalities in malignant human gliomas. Cancer Res 1988;48:405–11
8. Wong AJ, Ruppert JM, Eggleston J, Hamilton SR, Baylin SB, Vogelstein B. Gene amplification of c-myc and N-myc in small cell carcinoma of the lung. Science 1986;233:461–4
9. Donovan-Peluso M, Contento AM, Tobon H, Repepi B, Locker J. Oncogene amplification in breast cancer. Am J Pathol 1991;138: 835–45
10. Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci USA 1987;84:6899–6903
11. Chandar N, Lombardi B, Schulz W, Locker J. Analysis of RAS genes and linked viral sequences in rat hepatocarcinogenesis. Am J Pathol 1987;129:232–41
12. Burger PC, Vogel FS, Green SB, Strike TA. Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer 1985;56:1106–11
13. Burger PC, Vollmer RT. Histologic factors of prognostic significance in the glioblastoma multiforme. Cancer 1980;46:1179–86
14. Burger PC, Green SB. Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer 1987; 59:1617–25
15. Schiffer D, Chio A, Giordana MT, Leone M, Soflietti R. Prognostic value of histologic factors in adult cerebral astrocytoma. Cancer 1988;61:1386–93
16. Daumas-Duport C, Scheithauer B, O’Fallon J, Kelly P. Grading of astrocytomas. A simple and reproducible method. Cancer 1988; 62:2152–65
17. Zulch KJ, ed. Histological typing of tumors of the nervous system. International histological classification of tumors, no.21. Geneva: World Health organization, 1979
18. Fults D, Pedrone CA, Thomas GA, White R. Allelotype of human malignant astrocytoma. Cancer Res 1990;50:5784–9
19. Wasson JC, Saylors RL, Zeltzer P, et al. Oncogene amplification in pediatric brain tumors. Cancer Res 1990;50:2987–90
20. Humphrey PA, Wong AJ, Vogelstein B, et al. Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma. Proc Natl Acad Sci USA 1990;87:4207–11
21. Deininger PL, Jolly DJ, Rubin CM, Friedman T, Schmid CW. Base sequence studies of 300 nucleotide renatured repeated human DNA clones. J Mol Biol 1981; 151:17–33
22. Schwab M, Alitalo K, Klemprauer KH, Varmus HE, Bishop JM. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell line and a neuroblastoma tumor. (Letter) Nature 1983;305:245–8
23. Heiter PA, Maizel JV, Leder P. Evolution of human immunoglobulin. J Region Genes. J Biol Chem 1982;257:1516–22
24. Ullrich A, Coussens L, Hayflick JS, Dull TJ, Whittle N. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 1984;309:418–25
25. Cooper CS, Park M, Blair DG, et al. Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 1984;311:29–33
26. Alitalo K, Schwab M, Lin CC, Varmus HE, Bishop JM. Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. Proc Natl Acad Sci USA 1983;80:1707–11
27. Baas F, Bikker H, van Kessel AG, et al. The human thyroglobulin gene: A polymorphic marker localized distal to C-MYC on chromosome 8 band q 24. Hum Genet 1985;69:138–43